← Evidence map

ArticleScience translational medicine2012

Survivin is a therapeutic target in Merkel cell carcinoma.

Reety Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

79 papers cite itlatest 60 shown

2012
…
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22572880